Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 46 min ago
Peer-reviewedLicence not statedJAMA Cardiology

Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention

  • Muhammad Haisum Maqsood1
  • Frederick Feit2
  • Upendra Kaul3
  • Sunil V. Rao2
  • Daniele Giacoppo4
  • Adnan Kastrati5,6
  • Sripal Bangalore2
6 affiliations
  1. 1DeBakey Heart and Vascular Center, Department of Cardiology, The Methodist Hospital, Houston, Texas
  2. 2Division of Cardiovascular Medicine, New York University Grossman School of Medicine, New York
  3. 3Batra Hospital and Medical Research Centre, New Delhi, India
  4. 4Division of Cardiology, Azienda Ospedaliero–Universitaria Policlinico “Rodolico-San Marco,” University of Catania, Catania, Italy
  5. 5Department of Cardiology, Deutsches Herzzentrum München, TUM Universitätsklinikum, Munich, Germany
  6. 6German Center for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany
Open at sourceDOICite

Related

  1. Ticagrelor Monotherapy or Aspirin Plus Prasugrel After Percutaneous Coronary Intervention: A Network Meta-Analysis.
    Michele Maremmani, Enrico Citerni, Ovidio De Filippo +7
    JACC. AdvancesPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  2. Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―
    Kenji Kanenawa, Ko Yamamoto, Takenori Domei +23
    Circulation JournalPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineJ-STAGE
  3. Clinical Outcomes After Clopidogrel Versus Prasugrel Use in Endovascular Treatment of Unruptured Intracranial Aneurysms: A Propensity-Matched TriNetX Analysis
    M. H. Ibrahim, S. G. Ammanuel, T. Lhamo +1
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
  4. Ticagrelor versus prasugrel following PCI in acute coronary syndromes and high-risk coronary artery disease: A meta-analysis of one-year randomized trial outcomes
    Mohamed Ibrahim Gbreel, Ahmed Samy Badran, Daniel Robinson +10
    American heart journal plus : cardiology research and practicePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Deep dynamic coronary roadmap guidance in percutaneous coronary intervention: a deep learning approach
    Chih-Kuo Lee, Yen-An Lin, Chia-Ling Wu +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaCrossref

Cite

BibTeXRIS
BibTeX
@article{maqsood2026efficacy,
  title = {{Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention}},
  author = {Muhammad Haisum Maqsood and Frederick Feit and Upendra Kaul and Sunil V. Rao and Daniele Giacoppo and Adnan Kastrati and Sripal Bangalore},
  journal = {JAMA Cardiology},
  year = {2026},
  month = may,
  doi = {10.1001/jamacardio.2026.1128},
  url = {https://pubmed.ncbi.nlm.nih.gov/42201709/},
}
RIS
TY  - JOUR
TI  - Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention
AU  - Muhammad Haisum Maqsood
AU  - Frederick Feit
AU  - Upendra Kaul
AU  - Sunil V. Rao
AU  - Daniele Giacoppo
AU  - Adnan Kastrati
AU  - Sripal Bangalore
PY  - 2026
DA  - 2026/05/27
JO  - JAMA Cardiology
DO  - 10.1001/jamacardio.2026.1128
UR  - https://pubmed.ncbi.nlm.nih.gov/42201709/
SN  - 2380-6583
SN  - 2380-6591
ER  -